BPTH Price Targets and Analyst Ratings NASDAQ:BPTH
BPTH Forecast. What You Should Know.
BPTH Historical Ratings and Targets
About Bio-Path Holdings
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.